Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mechanism of NMDA receptor channel block by MK-801 and memantine.
Song X
,
Jensen MØ
,
Jogini V
,
Stein RA
,
Lee CH
,
Mchaourab HS
,
Shaw DE
,
Gouaux E
.
???displayArticle.abstract???
The NMDA (N-methyl-D-aspartate) receptor transduces the binding of glutamate and glycine, coupling it to the opening of a calcium-permeable ion channel 1 . Owing to the lack of high-resolution structural studies of the NMDA receptor, the mechanism by which ion-channel blockers occlude ion permeation is not well understood. Here we show that removal of the amino-terminal domains from the GluN1-GluN2B NMDA receptor yields a functional receptor and crystals with good diffraction properties, allowing us to map the binding site of the NMDA receptor blocker, MK-801. This crystal structure, together with long-timescale molecular dynamics simulations, shows how MK-801 and memantine (a drug approved for the treatment of Alzheimer's disease) bind within the vestibule of the ion channel, promote closure of the ion channel gate and lodge between the M3-helix-bundle crossing and the M2-pore loops, physically blocking ion permeation.
Adams,
PHENIX: building new software for automated crystallographic structure determination.
2002, Pubmed
Adams,
PHENIX: building new software for automated crystallographic structure determination.
2002,
Pubmed
Armstrong,
Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor.
2006,
Pubmed
,
Xenbase
Arnold,
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.
2006,
Pubmed
Baconguis,
Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes.
2012,
Pubmed
Bliss,
A synaptic model of memory: long-term potentiation in the hippocampus.
1993,
Pubmed
Chang,
The activation gate and gating mechanism of the NMDA receptor.
2008,
Pubmed
,
Xenbase
Chovancova,
CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures.
2012,
Pubmed
Davis,
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.
2007,
Pubmed
Dukkipati,
BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies.
2008,
Pubmed
Emsley,
Coot: model-building tools for molecular graphics.
2004,
Pubmed
Hackos,
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.
2016,
Pubmed
Hanson,
Crystal structure of a lipid G protein-coupled receptor.
2012,
Pubmed
Hart,
Scintillation proximity assay (SPA)--a new method of immunoassay. Direct and inhibition mode detection with human albumin and rabbit antihuman albumin.
1979,
Pubmed
Hu,
GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo.
2009,
Pubmed
Inouye,
Signal sequence of alkaline phosphatase of Escherichia coli.
1982,
Pubmed
Jensen,
Mechanism of voltage gating in potassium channels.
2012,
Pubmed
Jensen,
Atomic-level simulation of current-voltage relationships in single-file ion channels.
2013,
Pubmed
Jeschke,
Direct conversion of EPR dipolar time evolution data to distance distributions.
2002,
Pubmed
Johnson,
Glycine potentiates the NMDA response in cultured mouse brain neurons.
,
Pubmed
Kabsch,
XDS.
2010,
Pubmed
Karakas,
Crystal structure of a heterotetrameric NMDA receptor ion channel.
2014,
Pubmed
Karakas,
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
2011,
Pubmed
,
Xenbase
Kashiwagi,
Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore.
2002,
Pubmed
,
Xenbase
Klauda,
Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types.
2010,
Pubmed
Klepeis,
Long-timescale molecular dynamics simulations of protein structure and function.
2009,
Pubmed
Kovacic,
Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity.
2010,
Pubmed
Lee,
NMDA receptor structures reveal subunit arrangement and pore architecture.
2014,
Pubmed
,
Xenbase
Lipton,
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
2006,
Pubmed
MacKerell,
All-atom empirical potential for molecular modeling and dynamics studies of proteins.
1998,
Pubmed
Mackerell,
Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations.
2004,
Pubmed
Mayer,
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.
,
Pubmed
McCoy,
Solving structures of protein complexes by molecular replacement with Phaser.
2007,
Pubmed
Mishra,
Conformational dynamics of the nucleotide binding domains and the power stroke of a heterodimeric ABC transporter.
2014,
Pubmed
Murthy,
Probing the activation sequence of NMDA receptors with lurcher mutations.
2012,
Pubmed
Nowak,
Magnesium gates glutamate-activated channels in mouse central neurones.
,
Pubmed
Paoletti,
Molecular basis of NMDA receptor functional diversity.
2011,
Pubmed
Paoletti,
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.
2013,
Pubmed
Parsons,
Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
1995,
Pubmed
Parsons,
Extrasynaptic NMDA receptor involvement in central nervous system disorders.
2014,
Pubmed
Pierson,
GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine.
2014,
Pubmed
,
Xenbase
Reeves,
Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line.
2002,
Pubmed
Reisberg,
Memantine in moderate-to-severe Alzheimer's disease.
2003,
Pubmed
Roux,
The membrane potential and its representation by a constant electric field in computer simulations.
2008,
Pubmed
Simon,
Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.
1984,
Pubmed
Sobolevsky,
Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.
1998,
Pubmed
Stein,
A Straightforward Approach to the Analysis of Double Electron-Electron Resonance Data.
2015,
Pubmed
Stern,
Single channel properties of cloned NMDA receptors in a human cell line: comparison with results from Xenopus oocytes.
1994,
Pubmed
,
Xenbase
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Vanommeslaeghe,
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.
2010,
Pubmed
Vilar,
Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery.
2008,
Pubmed
Wollmuth,
Differential contribution of the NR1- and NR2A-subunits to the selectivity filter of recombinant NMDA receptor channels.
1996,
Pubmed
,
Xenbase
Wollmuth,
Structure and gating of the glutamate receptor ion channel.
2004,
Pubmed
Wollmuth,
Intracellular Mg2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel.
1998,
Pubmed
,
Xenbase
Yu,
Extension of the CHARMM General Force Field to sulfonyl-containing compounds and its utility in biomolecular simulations.
2012,
Pubmed
Yuan,
Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
2009,
Pubmed
,
Xenbase
Yuan,
Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects.
2015,
Pubmed
